San Francisco, California–(Newsfile Corp. – December 25, 2024) – ASP Isotopes Inc. (Nasdaq: ASPI) Some of its top executives are now involved in a securities class action lawsuit, alleging that the company deceived investors by making false and misleading statements about advanced nuclear fuel technologies.
Hagens Berman urges investors in ASP Isotopes who have suffered significant losses to file their losses now.
Class period: October 30, 2024 – November. 26, 2024
Lead Plaintiff Deadline: February 3, 2025
Visit: www.hbsslaw.com/investor-fraud/aspi
Contact the company now: ASPI@hbsslaw.com
844-916-0895
Class of securities ASP Isotopes Inc. (ASPI). an act (to:):
The lawsuit, filed in the U.S. District Court for the Southern District of New York, alleges that ASPI misled investors about the feasibility and potential of Aerodynamic Separation Process (ASP) and Quantum Enrichment (NASDAQ:) technologies.
The complaint alleges that ASPI overstated the effectiveness of its enrichment technologies, the development potential of its high-screen low-enriched uranium facility, and the performance of its nuclear fuel operating segment.
The truth came out on November 26, 2024, when a scathing report was released Fuzzy panda research It revealed that ASPI technology is old and unlikely to be commercially viable.
The report accused ASPI of using “obsolete and neglected laser enrichment technology” to falsely position itself as a cutting-edge nuclear fuel company. It also alleged that ASPI employed individuals to promote its shares and that its former executives Centros Energy (NYSE:) considered its technology “virtually worthless.”
After the report was released, ASPI's stock price fell by 23% in one trading day.
These events prompted equity firm Hagens Berman to open an investigation.
“We are investigating whether ASPI misled investors about the true commercial prospects of its ASP and Quantum Enrichment technologies,” said Reed Katherine, the partner leading the investigation.
If you invested in ASP Isotopes or have knowledge that may assist in the company's investigations, submit your losses now »
If you would like more information and answers to frequently asked questions about the ASP Isotopes case and our investigation, read more »
Whistleblowers: Persons with non-public information regarding ASP analogues should consider their options to assist in the investigation or utilize the SEC's whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, contact Catherine Reed at 844-916-0895 Or email ASPI@hbsslaw.com.
# # #
About Hagens Berman
Hagens Berman is a global, complex plaintiffs' rights litigation firm focused on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases that achieve real results for those harmed by corporate negligence and other wrongdoing. The Hagens Berman team has earned more than $2.9 billion in this area of law. More about the company and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235183
